BioArctic AB (publ) (STO:BIOA.B)
245.80
-13.60 (-5.24%)
Feb 21, 2025, 5:29 PM CET
BioArctic AB Employees
BioArctic AB had 107 employees as of December 31, 2024. The number of employees increased by 19 or 21.59% compared to the previous year.
Employees
107
Change (1Y)
19
Growth (1Y)
21.59%
Revenue / Employee
2.41M SEK
Profits / Employee
-1.65M SEK
Market Cap
21.73B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Swedish Orphan Biovitrum AB | 1,840 |
Getinge AB | 11,791 |
Sectra AB | 1,204 |
Camurus AB | 256 |
Medicover AB | 47,000 |
Vitrolife AB | 1,120 |
Elekta AB | 4,718 |
Vimian Group AB | 1,100 |
BioArctic AB News
- 5 days ago - Leqembi® sales reaches €200 million - first sales milestone achieved - PRNewsWire
- 27 days ago - FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer's Disease in the US - Benzinga
- 27 days ago - FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer's Disease in the US - PRNewsWire
- 5 weeks ago - FDA accepts Biologics License Application for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US - PRNewsWire
- 2 months ago - Leqembi® approved in Mexico - PRNewsWire
- 3 months ago - Leqembi® launched in South Korea - PRNewsWire
- 3 months ago - CHMP issues positive recommendation for approval of lecanemab in the EU - PRNewsWire
- 3 months ago - Eisai updates Leqembi® outlook for fiscal year 2024 (April 2024 - March 2025). Sales now expected to reach JPY 42.5 billion - PRNewsWire